These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12105306)

  • 1. Intrathecal methotrexate affects cognitive function in children with medulloblastoma.
    Riva D; Giorgi C; Nichelli F; Bulgheroni S; Massimino M; Cefalo G; Gandola L; Giannotta M; Bagnasco I; Saletti V; Pantaleoni C
    Neurology; 2002 Jul; 59(1):48-53. PubMed ID: 12105306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
    Yamasaki K; Okada K; Soejima T; Sakamoto H; Hara J
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28012. PubMed ID: 31544362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
    Kellie SJ; Chaku J; Lockwood LR; O'Regan P; Waters KD; Wong CK;
    Eur J Cancer; 2005 Jul; 41(11):1588-96. PubMed ID: 16026694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia: enhanced data analysis using an effect size model.
    Lesnik PG; Ciesielski KT; Hart BL; Benzel EC; Sanders JA
    Arch Neurol; 1998 Dec; 55(12):1561-8. PubMed ID: 9865801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.
    Massimino M; Cefalo G; Riva D; Biassoni V; Spreafico F; Pecori E; Poggi G; Collini P; Pollo B; Valentini L; Potepan P; Seregni E; Casanova M; Ferrari A; Luksch R; Polastri D; Terenziani M; Pallotti F; Clerici CA; Schiavello E; Simonetti F; Meazza C; Catania S; Podda M; Gandola L
    J Neurooncol; 2012 May; 108(1):163-71. PubMed ID: 22350379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal chemotherapy with antineoplastic agents in children.
    Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
    Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
    Rutkowski S; Bode U; Deinlein F; Ottensmeier H; Warmuth-Metz M; Soerensen N; Graf N; Emser A; Pietsch T; Wolff JE; Kortmann RD; Kuehl J
    N Engl J Med; 2005 Mar; 352(10):978-86. PubMed ID: 15758008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of brain tumors.
    Sadeh M
    N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938010
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood.
    Rønning C; Sundet K; Due-Tønnessen B; Lundar T; Helseth E
    Pediatr Neurosurg; 2005; 41(1):15-21. PubMed ID: 15886508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.
    Duffner PK; Armstrong FD; Chen L; Helton KJ; Brecher ML; Bell B; Chauvenet AR
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):8-15. PubMed ID: 24345882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma.
    Edwards MS; Levin VA; Seager ML; Wilson CB
    Childs Brain; 1981; 8(6):444-51. PubMed ID: 6796342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity.
    Naung H; Cohen KJ
    J Neurooncol; 2021 May; 152(3):567-572. PubMed ID: 33689104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center.
    Zhang YT; Wang Y; Zhong XD; Chang J
    J Neurooncol; 2023 Aug; 164(1):117-125. PubMed ID: 37474745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
    Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.
    Li Y; Vijayanathan V; Gulinello M; Cole PD
    Pharmacol Biochem Behav; 2010 Jun; 95(4):428-33. PubMed ID: 20332001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
    Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer.
    Butler RW; Hill JM; Steinherz PG; Meyers PA; Finlay JL
    J Clin Oncol; 1994 Dec; 12(12):2621-9. PubMed ID: 7989937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
    Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
    Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.